Abbott Laboratories (NYSE: ABT) — Company Overview, News & Financial Data
Abbott Laboratories is a global healthcare company offering pharmaceuticals, diagnostics, medical devices, and nutritional products.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad range of health products and medical technologies. The company operates across four primary business segments: Medical Devices, Diagnostics, Established Pharmaceuticals, and Nutrition. Its product portfolio includes continuous glucose monitoring systems, cardiovascular devices, core laboratory diagnostic equipment, rapid testing kits, branded generic pharmaceuticals, pediatric infant formulas, and adult clinical nutrition supplements. Abbott serves healthcare providers, institutions, and consumers across more than 160 countries, operating research, manufacturing, and distribution facilities globally to support healthcare delivery across diverse therapeutic areas.
Snapshot
Operations
Products and/or services of Abbott Laboratories
- Medical Devices - Diabetes Care: Development and manufacture of continuous glucose monitoring systems, biowearable sensors, and digital health software that track glucose levels in real time for individuals managing diabetes and metabolic health without requiring routine fingersticks.
- Medical Devices - Cardiovascular and Neuromodulation: Production of structural heart devices, cardiac electrophysiology systems, vessel closure tools, heart failure monitors, and implantable neuromodulation therapies designed to manage chronic pain, movement disorders, coronary artery disease, and structural heart conditions.
- Diagnostic Systems and Tests: Supply of automated core laboratory testing systems, molecular diagnostic instruments, point-of-care analyzers, and rapid infectious disease test kits utilized by hospitals, blood banks, reference laboratories, and clinics worldwide for clinical decision-making.
- Established Pharmaceuticals: Manufacture and commercial distribution of branded generic medications and specialty pharmaceuticals covering gastroenterology, cardiology, women's health, respiratory conditions, and metabolic disorders, marketed primarily across emerging geographic regions.
- Pediatric Nutrition: Formulation and global distribution of science-based infant formulas, follow-on formulas, oral rehydration solutions, and specialized pediatric nutritional products tailored for infant development, allergy management, and specific pediatric clinical requirements.
- Adult Nutrition: Production and sale of targeted adult clinical nutrition products, oral meal replacements, and dietary supplements designed to assist recovery, support muscle preservation, manage blood glucose levels, and fulfill specialized daily nutritional requirements.
Abbott Laboratories executive team
- Robert B. FordExecutive Chairman & CEO
- Philip P. BoudreauCFO & Executive VP of Finance
- Daniel Gesua Sive SalvadoriExecutive VP and Group President of Established Pharmaceuticals & Nutritional Products
- Christopher J. ScogginsExecutive Vice President of Diabetes Care
- Lisa D. EarnhardtExecutive VP & Group President of Medical Devices
- Sabina EwingSenior VP of Business & Technology Services and Chief Information Officer
- Michael ComillaVice President of Investor Relations.
- Erica L. BattagliaVP and Chief Ethics & Compliance Officer
- Elizabeth C. CushmanExecutive VP, General Counsel & Secretary
- Melissa BrotzSenior Vice President of Global Marketing & External Affairs